Our results showed that the METTL3 genome sequence was hypomethylated in ovarian tumor samples and cells, indicating that a high level of METTL3 correlated with poor prognosis of patients with ovarian cancer, and suggesting that METTL3 might participate in ovarian cancer development. This evidence concerns the gene METTL3 and ovarian cancer.